| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 9, 2007
Accepted on February 25, 2008
and PKC
in Endothelial Cells
From the Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Mass.
* To whom correspondence should be addressed. E-mail: george.king{at}joslin.harvard.edu.
Objective—Vascular endothelial growth factor (VEGF) stimulates proangiogenic signal transduction and cell function in part through activation of protein kinase C (PKC). Our aim was to examine how individual isoforms of PKC affect VEGF action.
Methods and Results—Transfection of bovine aortic endothelial cells with small interfering RNA (siRNA) targeting either PKC
,
, or
caused a reduction in the cognate PKC protein by 76% to 89% without changing expression of nontargeted isoforms. Downregulation of PKC
abrogated VEGF-stimulated phosphorylation of Akt at Ser473 and eNOS at Ser1179 and decreased VEGF-stimulated NO synthase activity in intact cells. In contrast, PKC
knockdown increased Akt and eNOS phosphorylation, whereas PKC
knockdown had no significant effect. PKC
knockdown also decreased VEGF-stimulated Erk1/2 phosphorylation and abolished VEGF-stimulated DNA synthesis. Consistent with an effect on several pathways of VEGF signaling, VEGF receptor-2 (VEGFR2) tyrosine phosphorylation and expression of VEGFR2 protein and mRNA was decreased by 81, 90, and 84%, respectively, during knockdown of PKC
, but increased during PKC
knockdown.
Conclusions—By regulating VEGFR2 expression and activation, PKC
expression is critical for activation of Akt and eNOS by VEGF and contributes to VEGF-stimulated Erk activation, whereas PKC
has opposite effects.
This article has been cited by other articles:
![]() |
M. Oubaha and J.-P. Gratton Phosphorylation of endothelial nitric oxide synthase by atypical PKC{zeta} contributes to angiopoietin-1-dependent inhibition of VEGF-induced endothelial permeability in vitro Blood, October 8, 2009; 114(15): 3343 - 3351. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Rothmeier, I. Ischenko, J. Joore, D. Garczarczyk, R. Furst, C. J. Bruns, A. M. Vollmar, and S. Zahler Investigation of the marine compound spongistatin 1 links the inhibition of PKC{alpha} translocation to nonmitotic effects of tubulin antagonism in angiogenesis FASEB J, April 1, 2009; 23(4): 1127 - 1137. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |